Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 140 Pages
Report ld: 6467821
Request Sample
Customized Report
Total Aflatoxin ELISA Kit Market Size(US$)

CAGR 2026-2032
6.9%
Market Size,2032
USD 535
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Total Aflatoxin ELISA Kit market was valued at US$ 337 million in 2025 and is anticipated to reach US$ 535 million by 2032, at a CAGR of 6.9% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Total Aflatoxin ELISA Kit competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Total Aflatoxin ELISA Kit is a competitive enzyme immunoassay for the screening of food and feed samples on the presence of this mycotoxin. For quantitative analysis of the total Aflatoxins in food and feed samples. The test is based on antibodies against Total Aflatoxin.
Total Aflatoxin are mycotoxins produced by Aspergillus flavus and Aspergillus parasiticus due to some reasons, and they are widely distributed in nature. There are about 20 kinds of its derivatives, of which aflatoxin B1 has the strongest toxicity and the strongest carcinogenicity. Aflatoxin have been found in pet and human food and raw materials for agricultural animals. As aflatoxin can reduce the productivity of livestock and poultry and cause liver necrosis, the U.S. FDA has set the maximum residue limit (MRL) of cereals and cereal products to 20 ppb, and the European Union (EU) has set the maximum residue limit (MRL) of edible oil to 4 ppb.
Compared with traditional methods,the Total Aflatoxin kit is simple, fast, and sensitive, and is...
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report delivers a comprehensive overview of the global Total Aflatoxin ELISA Kit market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Total Aflatoxin ELISA Kit. The Total Aflatoxin ELISA Kit market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Total Aflatoxin ELISA Kit market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Total Aflatoxin ELISA Kit manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Total Aflatoxin ELISA Kit manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Total Aflatoxin ELISA Kit sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Total Aflatoxin ELISA Kit Market Overview
1.1 Product Definition
1.2 Total Aflatoxin ELISA Kit by Type
1.2.1 Global Total Aflatoxin ELISA Kit Market Value by Type: 2025 vs 2032
1.2.2 48 Tests
1.2.3 96 Tests
1.2.4 Others
1.3 Total Aflatoxin ELISA Kit by Application
1.3.1 Global Total Aflatoxin ELISA Kit Market Value by Application: 2025 vs 2032
1.3.2 Food Industry
1.3.3 Feed Industry
1.3.4 Laboratories
1.3.5 Others
1.4 Global Total Aflatoxin ELISA Kit Market Size Estimates and Forecasts
1.4.1 Global Total Aflatoxin ELISA Kit Revenue 2021–2032
1.4.2 Global Total Aflatoxin ELISA Kit Sales 2021–2032
1.4.3 Global Total Aflatoxin ELISA Kit Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Total Aflatoxin ELISA Kit Market Competition by Manufacturers
2.1 Global Total Aflatoxin ELISA Kit Sales Market Share by Manufacturers (2021–2026)
2.2 Global Total Aflatoxin ELISA Kit Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Total Aflatoxin ELISA Kit Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Total Aflatoxin ELISA Kit, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Total Aflatoxin ELISA Kit, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Total Aflatoxin ELISA Kit, Product Types and Applications
2.7 Global Key Manufacturers of Total Aflatoxin ELISA Kit, Date of Entry into the Industry
2.8 Global Total Aflatoxin ELISA Kit Market Competitive Situation and Trends
2.8.1 Global Total Aflatoxin ELISA Kit Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Total Aflatoxin ELISA Kit Players Market Share by Revenue
2.8.3 Global Total Aflatoxin ELISA Kit Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Total Aflatoxin ELISA Kit Market Scenario by Region
3.1 Global Total Aflatoxin ELISA Kit Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Total Aflatoxin ELISA Kit Sales by Region: 2021–2032
3.2.1 Global Total Aflatoxin ELISA Kit Sales by Region: 2021–2026
3.2.2 Global Total Aflatoxin ELISA Kit Sales by Region: 2027–2032
3.3 Global Total Aflatoxin ELISA Kit Revenue by Region: 2021–2032
3.3.1 Global Total Aflatoxin ELISA Kit Revenue by Region: 2021–2026
3.3.2 Global Total Aflatoxin ELISA Kit Revenue by Region: 2027–2032
3.4 North America Total Aflatoxin ELISA Kit Market Facts & Figures by Country
3.4.1 North America Total Aflatoxin ELISA Kit Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Total Aflatoxin ELISA Kit Sales by Country (2021–2032)
3.4.3 North America Total Aflatoxin ELISA Kit Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Total Aflatoxin ELISA Kit Market Facts & Figures by Country
3.5.1 Europe Total Aflatoxin ELISA Kit Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Total Aflatoxin ELISA Kit Sales by Country (2021–2032)
3.5.3 Europe Total Aflatoxin ELISA Kit Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Total Aflatoxin ELISA Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Total Aflatoxin ELISA Kit Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Total Aflatoxin ELISA Kit Sales by Region (2021–2032)
3.6.3 Asia Pacific Total Aflatoxin ELISA Kit Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Total Aflatoxin ELISA Kit Market Facts & Figures by Country
3.7.1 Latin America Total Aflatoxin ELISA Kit Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Total Aflatoxin ELISA Kit Sales by Country (2021–2032)
3.7.3 Latin America Total Aflatoxin ELISA Kit Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Total Aflatoxin ELISA Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Total Aflatoxin ELISA Kit Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Total Aflatoxin ELISA Kit Sales by Country (2021–2032)
3.8.3 Middle East and Africa Total Aflatoxin ELISA Kit Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Total Aflatoxin ELISA Kit Sales by Type (2021–2032)
4.1.1 Global Total Aflatoxin ELISA Kit Sales by Type (2021–2026)
4.1.2 Global Total Aflatoxin ELISA Kit Sales by Type (2027–2032)
4.1.3 Global Total Aflatoxin ELISA Kit Sales Market Share by Type (2021–2032)
4.2 Global Total Aflatoxin ELISA Kit Revenue by Type (2021–2032)
4.2.1 Global Total Aflatoxin ELISA Kit Revenue by Type (2021–2026)
4.2.2 Global Total Aflatoxin ELISA Kit Revenue by Type (2027–2032)
4.2.3 Global Total Aflatoxin ELISA Kit Revenue Market Share by Type (2021–2032)
4.3 Global Total Aflatoxin ELISA Kit Price by Type (2021–2032)
5 Segment by Application
5.1 Global Total Aflatoxin ELISA Kit Sales by Application (2021–2032)
5.1.1 Global Total Aflatoxin ELISA Kit Sales by Application (2021–2026)
5.1.2 Global Total Aflatoxin ELISA Kit Sales by Application (2027–2032)
5.1.3 Global Total Aflatoxin ELISA Kit Sales Market Share by Application (2021–2032)
5.2 Global Total Aflatoxin ELISA Kit Revenue by Application (2021–2032)
5.2.1 Global Total Aflatoxin ELISA Kit Revenue by Application (2021–2026)
5.2.2 Global Total Aflatoxin ELISA Kit Revenue by Application (2027–2032)
5.2.3 Global Total Aflatoxin ELISA Kit Revenue Market Share by Application (2021–2032)
5.3 Global Total Aflatoxin ELISA Kit Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Biorex Food Diagnostics
6.1.1 Biorex Food Diagnostics Company Information
6.1.2 Biorex Food Diagnostics Description and Business Overview
6.1.3 Biorex Food Diagnostics Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Biorex Food Diagnostics Total Aflatoxin ELISA Kit Product Portfolio
6.1.5 Biorex Food Diagnostics Recent Developments/Updates
6.2 MyBioSource
6.2.1 MyBioSource Company Information
6.2.2 MyBioSource Description and Business Overview
6.2.3 MyBioSource Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 MyBioSource Total Aflatoxin ELISA Kit Product Portfolio
6.2.5 MyBioSource Recent Developments/Updates
6.3 Abbexa
6.3.1 Abbexa Company Information
6.3.2 Abbexa Description and Business Overview
6.3.3 Abbexa Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abbexa Total Aflatoxin ELISA Kit Product Portfolio
6.3.5 Abbexa Recent Developments/Updates
6.4 PerkinElmer
6.4.1 PerkinElmer Company Information
6.4.2 PerkinElmer Description and Business Overview
6.4.3 PerkinElmer Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 PerkinElmer Total Aflatoxin ELISA Kit Product Portfolio
6.4.5 PerkinElmer Recent Developments/Updates
6.5 BioVision(Abcam)
6.5.1 BioVision(Abcam) Company Information
6.5.2 BioVision(Abcam) Description and Business Overview
6.5.3 BioVision(Abcam) Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BioVision(Abcam) Total Aflatoxin ELISA Kit Product Portfolio
6.5.5 BioVision(Abcam) Recent Developments/Updates
6.6 Cepham Life Sciences
6.6.1 Cepham Life Sciences Company Information
6.6.2 Cepham Life Sciences Description and Business Overview
6.6.3 Cepham Life Sciences Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Cepham Life Sciences Total Aflatoxin ELISA Kit Product Portfolio
6.6.5 Cepham Life Sciences Recent Developments/Updates
6.7 Cusabio
6.7.1 Cusabio Company Information
6.7.2 Cusabio Description and Business Overview
6.7.3 Cusabio Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Cusabio Total Aflatoxin ELISA Kit Product Portfolio
6.7.5 Cusabio Recent Developments/Updates
6.8 R-Biopharm
6.8.1 R-Biopharm Company Information
6.8.2 R-Biopharm Description and Business Overview
6.8.3 R-Biopharm Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 R-Biopharm Total Aflatoxin ELISA Kit Product Portfolio
6.8.5 R-Biopharm Recent Developments/Updates
6.9 Immuno-Biological Laboratories
6.9.1 Immuno-Biological Laboratories Company Information
6.9.2 Immuno-Biological Laboratories Description and Business Overview
6.9.3 Immuno-Biological Laboratories Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Immuno-Biological Laboratories Total Aflatoxin ELISA Kit Product Portfolio
6.9.5 Immuno-Biological Laboratories Recent Developments/Updates
6.10 LIBIOS
6.10.1 LIBIOS Company Information
6.10.2 LIBIOS Description and Business Overview
6.10.3 LIBIOS Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 LIBIOS Total Aflatoxin ELISA Kit Product Portfolio
6.10.5 LIBIOS Recent Developments/Updates
6.11 Romer Labs
6.11.1 Romer Labs Company Information
6.11.2 Romer Labs Description and Business Overview
6.11.3 Romer Labs Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Romer Labs Total Aflatoxin ELISA Kit Product Portfolio
6.11.5 Romer Labs Recent Developments/Updates
6.12 Creative Diagnostics
6.12.1 Creative Diagnostics Company Information
6.12.2 Creative Diagnostics Description and Business Overview
6.12.3 Creative Diagnostics Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Creative Diagnostics Total Aflatoxin ELISA Kit Product Portfolio
6.12.5 Creative Diagnostics Recent Developments/Updates
6.13 Diagnostic Automation/Cortez Diagnostics
6.13.1 Diagnostic Automation/Cortez Diagnostics Company Information
6.13.2 Diagnostic Automation/Cortez Diagnostics Description and Business Overview
6.13.3 Diagnostic Automation/Cortez Diagnostics Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Diagnostic Automation/Cortez Diagnostics Total Aflatoxin ELISA Kit Product Portfolio
6.13.5 Diagnostic Automation/Cortez Diagnostics Recent Developments/Updates
6.14 Eurofins Technologies
6.14.1 Eurofins Technologies Company Information
6.14.2 Eurofins Technologies Description and Business Overview
6.14.3 Eurofins Technologies Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Eurofins Technologies Total Aflatoxin ELISA Kit Product Portfolio
6.14.5 Eurofins Technologies Recent Developments/Updates
6.15 Assay Genie
6.15.1 Assay Genie Company Information
6.15.2 Assay Genie Description and Business Overview
6.15.3 Assay Genie Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Assay Genie Total Aflatoxin ELISA Kit Product Portfolio
6.15.5 Assay Genie Recent Developments/Updates
6.16 Reagen
6.16.1 Reagen Company Information
6.16.2 Reagen Description and Business Overview
6.16.3 Reagen Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Reagen Total Aflatoxin ELISA Kit Product Portfolio
6.16.5 Reagen Recent Developments/Updates
6.17 Advanced Biomart
6.17.1 Advanced Biomart Company Information
6.17.2 Advanced Biomart Description and Business Overview
6.17.3 Advanced Biomart Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Advanced Biomart Total Aflatoxin ELISA Kit Product Portfolio
6.17.5 Advanced Biomart Recent Developments/Updates
6.18 Hygiena
6.18.1 Hygiena Company Information
6.18.2 Hygiena Description and Business Overview
6.18.3 Hygiena Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Hygiena Total Aflatoxin ELISA Kit Product Portfolio
6.18.5 Hygiena Recent Developments/Updates
6.19 United States Biological
6.19.1 United States Biological Company Information
6.19.2 United States Biological Description and Business Overview
6.19.3 United States Biological Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 United States Biological Total Aflatoxin ELISA Kit Product Portfolio
6.19.5 United States Biological Recent Developments/Updates
6.20 Aviva Systems Biology
6.20.1 Aviva Systems Biology Company Information
6.20.2 Aviva Systems Biology Description and Business Overview
6.20.3 Aviva Systems Biology Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Aviva Systems Biology Total Aflatoxin ELISA Kit Product Portfolio
6.20.5 Aviva Systems Biology Recent Developments/Updates
6.21 Agrisera
6.21.1 Agrisera Company Information
6.21.2 Agrisera Description and Business Overview
6.21.3 Agrisera Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Agrisera Total Aflatoxin ELISA Kit Product Portfolio
6.21.5 Agrisera Recent Developments/Updates
6.22 Neogen
6.22.1 Neogen Company Information
6.22.2 Neogen Description and Business Overview
6.22.3 Neogen Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Neogen Total Aflatoxin ELISA Kit Product Portfolio
6.22.5 Neogen Recent Developments/Updates
6.23 Elabscience
6.23.1 Elabscience Company Information
6.23.2 Elabscience Description and Business Overview
6.23.3 Elabscience Total Aflatoxin ELISA Kit Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Elabscience Total Aflatoxin ELISA Kit Product Portfolio
6.23.5 Elabscience Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Total Aflatoxin ELISA Kit Industry Chain Analysis
7.2 Total Aflatoxin ELISA Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Total Aflatoxin ELISA Kit Production Mode & Process Analysis
7.4 Total Aflatoxin ELISA Kit Sales and Marketing
7.4.1 Total Aflatoxin ELISA Kit Sales Channels
7.4.2 Total Aflatoxin ELISA Kit Distributors
7.5 Total Aflatoxin ELISA Kit Customer Analysis
8 Total Aflatoxin ELISA Kit Market Dynamics
8.1 Total Aflatoxin ELISA Kit Industry Trends
8.2 Total Aflatoxin ELISA Kit Market Drivers
8.3 Total Aflatoxin ELISA Kit Market Challenges
8.4 Total Aflatoxin ELISA Kit Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Total Aflatoxin ELISA Kit was estimated to be worth US$ 337 million in 2025 and is projected to reach US$ 535 million, growing at a CAGR of 6.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 163
USD 3950.00
(Single User License)
The global Total Aflatoxin ELISA Kit market size was US$ 318 million in 2024 and is forecast to a readjusted size of US$ 503 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 115
USD 4250.00
(Single User License)
The global Total Aflatoxin ELISA Kit market is projected to grow from US$ 318 million in 2024 to US$ 503 million by 2031, at a CAGR of 6.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 191
USD 4900.00
(Single User License)
The global market for Total Aflatoxin ELISA Kit was estimated to be worth US$ 318 million in 2024 and is forecast to a readjusted size of US$ 503 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 157
USD 3950.00
(Single User License)
The global market for Total Aflatoxin ELISA Kit was valued at US$ 318 million in the year 2024 and is projected to reach a revised size of US$ 503 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Published Date: 2025-01-13
Pages: 112
USD 2900.00
(Single User License)
Total Aflatoxin ELISA Kit is a competitive enzyme immunoassay for the screening of food and feed samples on the presence of this mycotoxin. For quantitative analysis of the total Aflatoxins in food and feed samples. The test is based on antibodies against Total Aflatoxin.
Published Date: 2024-02-05
Pages: 111
USD 2900.00
(Single User License)
The global market for Total Aflatoxin ELISA Kit was estimated to be worth US$ 337 million in 2025 and is projected to reach US$ 535 million, growing at a CAGR of 6.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 163
The global Total Aflatoxin ELISA Kit market size was US$ 318 million in 2024 and is forecast to a readjusted size of US$ 503 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 115
The global Total Aflatoxin ELISA Kit market is projected to grow from US$ 318 million in 2024 to US$ 503 million by 2031, at a CAGR of 6.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 191
The global market for Total Aflatoxin ELISA Kit was estimated to be worth US$ 318 million in 2024 and is forecast to a readjusted size of US$ 503 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 157
The global market for Total Aflatoxin ELISA Kit was valued at US$ 318 million in the year 2024 and is projected to reach a revised size of US$ 503 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Published: 2025-01-13
Pages: 112
Total Aflatoxin ELISA Kit is a competitive enzyme immunoassay for the screening of food and feed samples on the presence of this mycotoxin. For quantitative analysis of the total Aflatoxins in food and feed samples. The test is based on antibodies against Total Aflatoxin.
Published: 2024-02-05
Pages: 111
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now